We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 961 results
  1. Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure

    Following reverse transcription, HIV viral DNA is integrated into host cell genomes and establishes a stable latent infection, which has posed a...

    Edrous Alamer, Chaojie Zhong, ... Haitao Hu in Retrovirology
    Article Open access 07 January 2021
  2. iPSC-derived three-dimensional brain organoid models and neurotropic viral infections

    Progress in stem cell research has revolutionized the medical field for more than two decades. More recently, the discovery of induced pluripotent...

    Michael Swingler, Martina Donadoni, ... Ilker K. Sariyer in Journal of NeuroVirology
    Article 25 April 2023
  3. Opioid abuse and SIV infection in non-human primates

    Human immunodeficiency virus (HIV) and drug abuse are intertwined epidemics, leading to compromised adherence to combined antiretroviral therapy...

    Uma Maheswari Deshetty, Sudipta Ray, ... Palsamy Periyasamy in Journal of NeuroVirology
    Article 07 July 2023
  4. The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation

    The persistence of latent HIV-1 reservoirs throughout combination antiretroviral therapy (cART) is a major barrier on the path to achieving a cure...

    Xuan-xuan Zhang, Jian Lin, ... Shu-wen Liu in Acta Pharmacologica Sinica
    Article 22 May 2018
  5. The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments

    Background

    Chimeric antigen receptor-T (CAR-T) cells therapy is one of the novel immunotherapeutic approaches with significant clinical success....

    Tao Chen, Jieyi Deng, ... Hui Zhang in Molecular Cancer
    Article Open access 11 March 2024
  6. Effect of Opioid Use on Immune Activation and HIV Persistence on ART

    While there is an emerging consensus that engagement of the Mu opioid receptor by opioids may modulate various stages the HIV life cycle (e.g.:...

    Livio Azzoni, David Metzger, Luis J. Montaner in Journal of Neuroimmune Pharmacology
    Article 25 September 2020
  7. Does antiretroviral therapy alter the course of Parkinson’s disease in people living with HIV?

    South Africa has the world’s largest antiretroviral programme which has resulted in an increase in life expectancy in persons living with HIV....

    Ferzana Hassan Amod, Ahmed Iqbal Bhigjee, Anand Moodley in Journal of NeuroVirology
    Article 05 August 2021
  8. Sexual dimorphism in HIV-1 infection

    Sex-specific differences affecting various aspects of HIV-1 infection have been reported, including differences in susceptibility to infection,...

    Anne Rechtien, Marcus Altfeld in Seminars in Immunopathology
    Article 01 October 2018
  9. Revisiting JC virus and progressive multifocal leukoencephalopathy

    Since its definition 65 years ago, progressive multifocal leukoencephalopathy (PML) has continued to devastate a growing population of...

    Angela Rocchi, Ilker K. Sariyer, Joseph R. Berger in Journal of NeuroVirology
    Article 02 September 2023
  10. The immunology of long COVID

    Long COVID is the patient-coined term for the disease entity whereby persistent symptoms ensue in a significant proportion of those who have had...

    Daniel M. Altmann, Emily M. Whettlock, ... Rosemary J. Boyton in Nature Reviews Immunology
    Article 11 July 2023
  11. Combating antimicrobial resistance in malaria, HIV and tuberculosis

    Antimicrobial resistance poses a significant threat to the sustainability of effective treatments against the three most prevalent infectious...

    Maëlle Duffey, Robert W. Shafer, ... Didier Leroy in Nature Reviews Drug Discovery
    Article 15 May 2024
  12. Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases

    By binding to multiple antigens simultaneously, multispecific antibodies are expected to substantially improve both the activity and long-term...

    Camille Rolin, Jacques Zimmer, Carole Seguin-Devaux in Cellular & Molecular Immunology
    Article Open access 24 May 2024
  13. Zoonotic Transmission of Chlamydia spp.: Known for 140 Years, but Still Underestimated

    Historically, the first documented cases of infections by chlamydiae involved humans with contact to psittacine birds. While birds have remained the...
    Nicole Borel, Konrad Sachse in Zoonoses: Infections Affecting Humans and Animals
    Reference work entry 2023
  14. Nanomedicine in the Treatment of Viral Diseases

    In this chapter, you will learn about virus, its morphology, classification, structure, pathogenesis, and hurdles in viral invasion of host cells....
    Ammara Akhtar, Muhammad Ijaz, ... Javeria Pervaiz in Nanomedicine in Treatment of Diseases
    Chapter 2023
  15. Zoonotic Transmission of Chlamydia spp.: Known for 140 Years, but Still Underestimated

    Historically, the first documented cases of infections by chlamydiae involved humans with contact to psittacine birds. While birds have remained the...
    Nicole Borel, Konrad Sachse in Zoonoses: Infections Affecting Humans and Animals
    Living reference work entry 2023
  16. Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4+ T cells to reduce the latent HIV+ cell reservoir

    Chimeric Antigen Receptor (CAR)-redirected T cells show great efficacy in the patient-specific therapy of hematologic malignancies. Here, we...

    Lea Patasic, Janna Seifried, ... Klaus Cichutek in Medical Microbiology and Immunology
    Article Open access 12 September 2020
  17. Lysine-specific demethylase 1 cooperates with BRAF–histone deacetylase complex 80 to enhance HIV-1 Tat-mediated transactivation

    Despite the notable success of combination antiretroviral therapy, how to eradicate latent HIV-1 from reservoirs poses a challenge. The Tat protein...

    Yu Liu, Deyu Zhou, ... **aohong Kong in Virus Genes
    Article 13 August 2018
  18. HIV infection of non-classical cells in the brain

    HIV-associated neurological disorders (HAND) affect up to 50% of people living with HIV (PLWH), even in the era of combination antiretroviral therapy...

    Angela Wahl, Lena Al-Harthi in Retrovirology
    Article Open access 13 January 2023
  19. Benefits and limitations of humanized mice in HIV persistence studies

    Significant advances in the treatment of HIV infection have been made in the last three decades. Antiretroviral therapy (ART) is now potent enough to...

    Matthew D. Marsden in Retrovirology
    Article Open access 06 April 2020
Did you find what you were looking for? Share feedback.